Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-04-08
2009-06-02
Yaen, Christopher H (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07541150
ABSTRACT:
Methods for the diagnosis of cancer by determining the neoplastic status of a cell by probing the cell plasma membrane for the presence of nucleolin are provided, as are kits to carry out such tests.
REFERENCES:
patent: 4474892 (1984-10-01), Murad et al.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4665897 (1987-05-01), Lemelson
patent: 5093246 (1992-03-01), Cech et al.
patent: 5192660 (1993-03-01), Reed-Gitomer
patent: 5545807 (1996-08-01), Surani et al.
patent: 5567595 (1996-10-01), Kok
patent: 5629197 (1997-05-01), Ring et al.
patent: 5736348 (1998-04-01), Goldenberg et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5925334 (1999-07-01), Rubin et al.
patent: 5932475 (1999-08-01), Bandman et al.
patent: 6048703 (2000-04-01), Siman et al.
patent: 6096532 (2000-08-01), Armstrong et al.
patent: 6291643 (2001-09-01), Zou et al.
patent: 6306404 (2001-10-01), LaPosta et al.
patent: 6325785 (2001-12-01), Babkes et al.
patent: 6339075 (2002-01-01), King et al.
patent: 6350452 (2002-02-01), Riss
patent: 6462189 (2002-10-01), Koide
patent: 6506559 (2003-01-01), Fire et al.
patent: 2002/0028488 (2002-03-01), Singh et al.
patent: 2004/0132049 (2004-07-01), Bates et al.
patent: 2005/0053607 (2005-03-01), Bates et al.
patent: 10037861 (2002-02-01), None
patent: 07 242566 (1995-09-01), None
patent: WO 95/20401 (1995-08-01), None
patent: WO 97/22250 (1997-06-01), None
patent: WO 98/24893 (1998-06-01), None
patent: WO 98/40480 (1998-09-01), None
patent: WO 9840480 (1998-09-01), None
patent: WO 99/06588 (1999-02-01), None
patent: WO00/61597 (2000-10-01), None
patent: WO 00/61597 (2000-10-01), None
patent: WO 00/63250 (2000-10-01), None
patent: WO 01/32832 (2001-05-01), None
patent: WO 01/35093 (2001-05-01), None
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 01/91787 (2001-12-01), None
patent: WO 02/12437 (2002-02-01), None
patent: WO 02/44231 (2002-06-01), None
patent: WO 03/029277 (2003-04-01), None
patent: WO 03/005617 (2003-10-01), None
patent: WO03/086174 (2003-10-01), None
patent: WO 03/086174 (2003-10-01), None
patent: WO03/087124 (2003-10-01), None
patent: WO 03/087124 (2003-10-01), None
patent: WO 2004/003554 (2004-01-01), None
patent: WO 2005/035579 (2005-04-01), None
Haese A (Urologe A Sep. 2003;42(9):1172-1187—Abstract Only.
Mikolajczyk et al Rinsho Byori. Mar. 2004; 52(3):223-30.
Nonomura et al (Surg Today 1993:23(6):486-490).
Kennedy et al (Chest 2000;117(Suppl 1):72S-79S).
Harms et al (Biochem J. 2001; 360:531-538).
http://www.abcam.com/?datasheet=7898.
Nature Reviews Dec. 2000; 1:233-236.
Bates, P.J., J.B. Kahlon, S.D. Thomas, JO. Trent et al 1999 Antiprohferative activity of G-rich oligonucleotides correlates with protein binding.JBE()l Chem.274:26369-77.
Callebaut, C., J. Blanco, N. Benkirane, B. Krust, et al 1998. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells.JBiol Chem.273:21988-97.
Carney, D.N., A.F. Gazdar, U. Bepler, J.G. Guccion, et al 1985. Establishment and 10 identification of small cell lung cancer cell lines having classic and variant features.Cancer Res.45:2913-23.
Davis, K.A., Y. Lin, B. Abrams, and S.D. .Jayasena. 1998. Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry.Nucleic Acids Res.26:3915-24.
Derenzini, M. 2000. The AgNORs.Micron.3 1:117-20.
Gey, G., W. Coffman, and M. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium.Cancer Res.12:264.
Giaccone, U., J. Battey, A.F. Gazdar, H. Oie, et al 1992. Neuromedin B is present in 20 lung cancer cell lines.Cancer Res.52:2732s-2736s.
Ginisty, H., H. Sicard, B. Roger, and P. Bouvet. 1999. Structure and functions of nucleolin.J Cell SeE.112:761-72.
Kim, CS., B.B. Berkley, W.M. Abraham, and A. Wanner. 1982. A micro double capillary method for rheologic measurements of lower airway secretions.Bull Eur Physiopathol Respir.18:915-27.
Langer, P.R., A.A. Waldrop, and D.C. Ward. 1981. Enzymatic synthesis of biotinlabeled polynucleotides: novel nucleic acid affinity probes.Proc Natl Acad Sci USA.78:6633-7.
Lin, D.L., and C. Chang. 1996. p53 is a mediator for radiation-repressed human 1R2 orphan receptor expression in MCF-7 cells, a new pathway from tumor suppressor to member of the steroid receptor superfamily.JBI()l Chem.271: 14649-52.
Little, CD., M.M. Nau, D.N. Carney, A.F. Gazdar, et at 1983. Amplification and expression of thec-myconcogene in human lung cancer cell lines.Nature.306:194-6.
McNicol, AM., and J.A. Richmond. 1998. Optimizing immunohistochemistry: antigen retrieval and signal amplification.Histopathology.32:97-103.
Mickey, D.D., KR. Stone, H. Wunderli, G.H. Mickey, et at 1977. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice.Cancer Res.37:4049-58.
Naito, M., H. Hamada, and T. Tsuruo. 1988. AIP/Mg -dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.JBIol Chem.263:11887-91.
Orfao, A., and A Ruiz-Arguelles. 1996. General concepts about cell sorting techniques.GlEn Biochem29:5-9.
Robinson, J.M., and D.D. Vandre. 2001. Antigen retrieval in cells and tissues: enhancement with sodium dodecyl sulfate.Histochern CellBiol.116:119-30.
Shi, SR., R.J. Cote, and CR. Taylor. 1997. Antigen retrieval immunohistochemistry: past, present, and future.JHistochem Cytochem.45:327-43.
Shi, S.R., R.J. Cote, and CR. Taylor. 2001. Antigen retrieval techniques: current perspectives.JHistochenz Cytochem.49:931-7.
Sorokina, E.A., and JO. Kleinman. 1999. Cloning and preliminary characterization of a calcium-binding protein closely related to nucleolin on the apical surface of inner medullary collecting duct cells.J Biol Chern.274:27491-6.
Srivastava, M., and H.B. Pollard. 1999. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights.FasebJ.13:1911-22.
Stone, K.R., D.D. Mickey, H. Wunderli, G.H. Mickey, et at 1978. Isolation of a human prostate carcinoma cell line (DU 145).Int J Cancer.21:274-81.
Takahashi, T., M.M. Nau, I. Chiba, Mi. Birrer, et at 1989. p53: a frequent target for genetic abnormalities in lung cancer.Science.246:491-4.
Tockman, MS., J.L. Mulshine, S. Piantadosi, Y.S. Erozan, et at 1997. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.Clin Cancer Res.3:2237-46.
Tuteja, R., and N. Tuteja. 1998. Nucleolin: a multifunctional major nucleolar phosphoprotein.Grit Rev Biocheni Mol Biol.33:407-36.
van de Loosdrecht, A.A., R.H. Beelen, G.J. Ossenkoppele, MG Broekhoven, et at 1994. A tetrazolium-based colorimetric MTI assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.Jmmnzunol Methods.174:311-20.
Wysocki, L.J., and V.L. Sato. 1978. “Panning” for lymphocytes: a method for cell selection.Proc Natl Acad Sd US A.75:2844-8.
Xu, X., F. Hamhouyia, S.D. Thomas, T.J. Burke, et at 2001. Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by 0-rich Oligonucleotides.JBiol Chem.276:43221-30.
Yao, G.Q., S. Corrias, and Y.C. Cheng. 1996a. Identification of two oligodeoxyribonucleotide binding proteins on plasma membranes of human cell lines.Biochern Pharmacol.51:431-6.
Ballou, B., et al., “Three-Dimensional Imaging of Nucleolin Traffocking in Normal Cells, Transfectants, and Heterokaryons”, 1996, SPIE, vol. 2680, pp. 124-131.
Ballou, B., et al., “Tumor Detection and Visualization Using Cyanine Fluorochrome-Labeled Antibodies”, 1997, Biotechnol. Prog., 13, pp. 649-658.
Ballou, B., et al., “Tumor Labeling in Vivo Using Cyanine-Conjugated Monoclonal Antibodies”, 1995, Cancer Immunol Immunother 41, pp. 257-263.
Ballou, B., et al., Abstract of Cyanine Fluorocrome-Labeled Antibodies In Vivo: Assessment of Tumor Imaging Using Cy3, Cy5, Cy5.5, and Cy7., 1998, Cancer Detect Prev. 22(3), pp. 251-257.
Hovanessian, et al., The Cell-Surface-Expressed
Bates Paula J.
Miller Donald M.
Trent John O.
Xu Xiaohua
Evan Law Group LLC
University of Louisville Research Foundation, Inc
Yaen Christopher H
LandOfFree
Method for the diagnosis and prognosis of malignant diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the diagnosis and prognosis of malignant diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the diagnosis and prognosis of malignant diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134082